Anne Marie Api, PhD
Vice President, Human Health Sciences
Research Institute for Fragrance Materials
Renee Bergeron, PhD
Executive Director, Project Safety Assessment
Novartis Institutes for Biomedical Research
Laura Custer, PhD
Head of Genetic Toxicology and Associate Director
Bristol-Myers Squibb
Marcus Dey, PhD
Director, Program Development, Toxicological Sciences, and Imaging at Merck
Marie Fortin, PhD, DABT
Senior Manager, Toxicology, Alcami
Advisors: Drs. Jason Richardson & Nancy Fiedler
No Photo Available
Wendy Freebern, PhD, DABT
Associate Director, Department of Immunology
Bristol-Myers Squibb
Kristian Fried, PhD, DABT
Regulatory Toxicology & Oral Care Category Team Leader
Colgate-Palmolive
Gary Grover, PhD
Adjunct Professor
Rutgers University
Imad Hanna, PhD
Director, Drug Metabolism and Pharmacokinetics
Novartis Institutes for Biomedical Research
Jacqueline Kinyamu-Akunda, DVM, MSc, PhD
Director, Pre-Clinical Safety – Oncology
Novartis Institutes for Biomedical Research
Guillaume Normand, PhD
Principal Research Investigator, Imaging
Novartis Institutes for Biomedical Research
Ravikumar Peri, PhD, DABT
Senior Research Investigator II
Bristol-Myers Squibb
Kary Thompson, PhD
Associate Director, Drug Safety Evaluation
Bristol-Myers Squibb
Ron White, PhD
Executive Pharmaceutical Consultant
Synergy Partners R&D Solutions